Cervical cancer, despite being largely preventable, continues to claim the lives of two women in the UK every day—a stark reminder of the ongoing battle against the disease. In a bid to change this grim statistic, NHS England has committed to an ambitious goal of eliminating cervical cancer by
The ability to control matter at the atomic level with remarkable precision has long been a dream in the field of nanotechnology. Recent advancements led by physicists at the University of Bath, in collaboration with an international team, have brought us closer to this goal. This breakthrough
In a groundbreaking development, QIMR Berghofer has made significant strides in combating severe viral infections in immunocompromised patients through their pioneering cell therapy. This innovative treatment has proven effective in 46 out of 71 patients, resulting in a notable 65% success rate.
Amgen's obesity drug candidate, MariTide (maridebart cafraglutide, formerly AMG 133), has brought forward promising results in a Phase II clinical trial, sparking hope for a new and effective treatment for obesity. With its innovative design and impressive efficacy, MariTide is positioned as a
Triple-negative breast cancer (TNBC) is a particularly aggressive form of breast cancer, accounting for 15-20% of all breast cancer cases. Known for its poor prognosis and lack of effective treatment options, TNBC presents a significant challenge in oncology. However, recent advancements in spatial
Heart disease remains a leading cause of mortality worldwide, with heart failure accounting for 13 percent of global deaths. The inability of the human heart to regenerate lost muscle cells after birth has driven the exploration of cell-based therapies. Over the past two decades, significant
Imagine a world where healing damaged tissues and organs becomes much more efficient, accelerating recovery times for countless patients. This is the promise that scaffold technology, a growing field in tissue engineering and regenerative medicine, offers. According to recent analysis, the global
Mental healthcare has long relied on subjective methods for diagnosing and treating conditions. The Diagnostic and Statistical Manual of Mental Disorders (DSM) has been the cornerstone of this approach, guiding clinicians through a polythetic diagnostic process based on observed symptoms and
Roche is making a bold move in the field of allogeneic cell therapy with its recent acquisition of Poseida Therapeutics, a San Diego-based biotech firm. This $1 billion upfront deal underscores Roche's commitment to expanding its portfolio in cell and gene therapies, particularly targeting blood
The article "Cardiovascular disease risk linked to early brain decline in men," published in the Journal of Neurology Neurosurgery & Psychiatry, examines the correlation between cardiovascular disease risk factors and brain health decline, with a specific focus on gender differences. The research
